GoodRx Holdings, Inc.
NASDAQ:GDRX
4.89 (USD) • At close November 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 195.251 | 200.61 | 197.88 | 196.644 | 179.958 | 189.677 | 183.986 | 184.109 | 187.318 | 191.798 | 203.329 | 213.256 | 195.102 | 176.635 | 160.431 | 153.544 | 140.453 | 123.295 | 133.408 | 113.256 | 101.745 | 91.534 | 86.612 |
| Cost of Revenue
| 11.684 | 28.835 | 28.41 | 57.506 | 18.721 | 16.339 | 16.695 | 17.36 | 17.395 | 18.044 | 12.28 | 13.927 | 11.271 | 11.09 | 10.428 | 9.204 | 7.54 | 6.824 | 6.019 | 4.596 | 3.396 | 3.142 | 3.012 |
| Gross Profit
| 183.567 | 171.775 | 169.47 | 139.138 | 161.237 | 173.338 | 167.291 | 166.749 | 169.923 | 173.754 | 191.049 | 199.329 | 183.831 | 165.545 | 150.003 | 144.34 | 132.913 | 116.471 | 127.389 | 108.66 | 98.349 | 88.392 | 83.6 |
| Gross Profit Ratio
| 0.94 | 0.856 | 0.856 | 0.708 | 0.896 | 0.914 | 0.909 | 0.906 | 0.907 | 0.906 | 0.94 | 0.935 | 0.942 | 0.937 | 0.935 | 0.94 | 0.946 | 0.945 | 0.955 | 0.959 | 0.967 | 0.966 | 0.965 |
| Reseach & Development Expenses
| 30.139 | 30.854 | 31.017 | 31.532 | 39.611 | 31.285 | 32.908 | 36.77 | 35.921 | 35.404 | 35.042 | 35.06 | 35.073 | 29.567 | 26.16 | 23.683 | 15.846 | 11.962 | 10.325 | 9.82 | 7.844 | 5.997 | 5.818 |
| General & Administrative Expenses
| 25.619 | 27.589 | 41.108 | 30.371 | 35.317 | 27.188 | 29.619 | 28.581 | 49.548 | 34.74 | 31.923 | 35.374 | 35.947 | 39.579 | 43.786 | 340.753 | 108.479 | 6.332 | 5.887 | 4.527 | 4.102 | 3.435 | 2.545 |
| Selling & Marketing Expenses
| 89.867 | 93.454 | 89.964 | 93.751 | 91.615 | 80.46 | 78.522 | 84.128 | 86.215 | 94.338 | 92.95 | 106.491 | 95.651 | 88.381 | 79.694 | 74.94 | 65.113 | 51.92 | 63.162 | 54.328 | 44.95 | 37.766 | 38.845 |
| SG&A
| 115.486 | 120.303 | 118.023 | 123.057 | 126.932 | 107.648 | 108.141 | 112.709 | 135.763 | 129.078 | 124.873 | 141.865 | 131.598 | 127.96 | 123.48 | 415.693 | 173.592 | 58.252 | 69.049 | 58.855 | 49.052 | 41.201 | 41.389 |
| Other Expenses
| 17.535 | 16.965 | 15.942 | 43.608 | -2.2 | 16.097 | 14.939 | 15.533 | 13.952 | 13.319 | 11.373 | 10.648 | 10.161 | 8.369 | 5.361 | 0.002 | -0.001 | 0.016 | 0.005 | -2.97 | 0.004 | 0 | 0 |
| Operating Expenses
| 163.16 | 151.157 | 149.04 | 154.589 | 199.567 | 155.03 | 155.988 | 165.012 | 185.636 | 177.801 | 171.288 | 187.573 | 176.832 | 165.896 | 155.001 | 443.78 | 194.598 | 74.735 | 83.719 | 72.893 | 60.505 | 50.325 | 50.568 |
| Operating Income
| 20.407 | 20.618 | 20.43 | -15.451 | -38.33 | 18.308 | 16.729 | 7.182 | -12.793 | -3.19 | 19.761 | 11.756 | 6.999 | -0.351 | -4.998 | -299.44 | -61.685 | 41.736 | 43.67 | 35.767 | 37.844 | 38.07 | 33.52 |
| Operating Income Ratio
| 0.105 | 0.103 | 0.103 | -0.079 | -0.213 | 0.097 | 0.091 | 0.039 | -0.068 | -0.017 | 0.097 | 0.055 | 0.036 | -0.002 | -0.031 | -1.95 | -0.439 | 0.339 | 0.327 | 0.316 | 0.372 | 0.416 | 0.387 |
| Total Other Income Expenses Net
| -12.295 | -8.972 | -20.137 | -9.184 | -2.2 | -6.24 | -13.133 | -11.927 | -9.478 | -6.969 | -5.817 | -5.903 | -5.915 | -5.893 | -5.889 | 0.002 | -0.001 | 0.016 | 0.005 | -7.847 | 0.004 | -13.103 | -13.673 |
| Income Before Tax
| 8.112 | 11.646 | 0.293 | -24.635 | -46.601 | 12.068 | 3.596 | -4.745 | -22.271 | -10.159 | 13.944 | 5.87 | 1.084 | -6.244 | -10.887 | -305.634 | -67.926 | 34.998 | 35.112 | 17.938 | 25.346 | 24.967 | 19.847 |
| Income Before Tax Ratio
| 0.042 | 0.058 | 0.001 | -0.125 | -0.259 | 0.064 | 0.02 | -0.026 | -0.119 | -0.053 | 0.069 | 0.028 | 0.006 | -0.035 | -0.068 | -1.991 | -0.484 | 0.284 | 0.263 | 0.158 | 0.249 | 0.273 | 0.229 |
| Income Tax Expense
| -4.147 | 4.952 | 1.302 | 1.234 | -8.106 | -46.718 | 6.886 | -2.773 | 19.463 | -8.744 | 1.651 | 45.784 | 19.153 | -37.305 | -12.555 | -7.36 | -17.894 | 7.661 | 7.766 | 2.711 | 5.727 | 5.317 | 4.246 |
| Net Income
| 12.259 | 6.694 | -1.009 | -25.869 | -38.495 | 58.786 | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 | -18.069 | 31.061 | 1.668 | -298.274 | -50.032 | 27.337 | 27.346 | 15.227 | 19.619 | 19.65 | 10.013 |
| Net Income Ratio
| 0.063 | 0.033 | -0.005 | -0.132 | -0.214 | 0.31 | -0.018 | -0.011 | -0.223 | -0.007 | 0.06 | -0.187 | -0.093 | 0.176 | 0.01 | -1.943 | -0.356 | 0.222 | 0.205 | 0.134 | 0.193 | 0.215 | 0.116 |
| EPS
| 0.032 | 0.018 | -0.003 | -0.064 | -0.093 | 0.14 | -0.008 | -0.005 | -0.1 | -0.003 | 0.03 | -0.1 | -0.044 | 0.08 | 0.004 | -0.74 | -0.21 | 0.071 | 0.077 | 0.043 | 0.055 | 0.087 | 0.044 |
| EPS Diluted
| 0.032 | 0.017 | -0.003 | -0.064 | -0.093 | 0.14 | -0.008 | -0.005 | -0.1 | -0.003 | 0.029 | -0.097 | -0.044 | 0.07 | 0.004 | -0.74 | -0.21 | 0.071 | 0.075 | 0.043 | 0.054 | 0.087 | 0.044 |
| EBITDA
| 13.292 | 37.583 | 36.372 | 29.239 | 1.143 | 42.219 | 31.668 | 22.715 | 1.159 | 10.129 | 31.186 | 22.421 | 17.173 | 8.031 | 0.379 | -295.014 | -56.502 | 46.314 | 48.095 | 32.273 | 41.728 | 40.943 | 36.393 |
| EBITDA Ratio
| 0.068 | 0.187 | 0.184 | 0.149 | 0.006 | 0.223 | 0.172 | 0.123 | 0.006 | 0.053 | 0.153 | 0.105 | 0.088 | 0.045 | 0.002 | -1.921 | -0.402 | 0.376 | 0.361 | 0.285 | 0.41 | 0.447 | 0.42 |